CClinicalTrials.gg
Status unknownNCT03827369Updated Mar 27, 2020

The Blood Pressure Analysis on Critically Ill Patients

An observational study in Multiple Organ Failure and Intensive Care Unit Syndrome, sponsored by Taoyuan General Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years to 99 Years. Per ClinicalTrials.gov, last updated 2020-03-27.

Sponsored by Taoyuan General Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
20 Years to 99 Years
Sex
All
01

Study summary

The study is to explore the relationship between coefficient of variation of harmonic magnitude (HCV) and different organ failures among those critically ill patients. In the future, we can act as a warning system on patients with multiple organ failures or terminal illness, also as an indicator of treatment effect.

02

Conditions studied

  • Multiple Organ Failure
  • Intensive Care Unit Syndrome

Keywords

  • Blood pressure
  • Arterial pulse
  • Coefficient of variation of harmonic magnitude
03

In context

Multiple Organ Failure

156 studies on the registry are indexed under Multiple Organ Failure; 44 are open to participants now.

This study's planned enrollment of 100 is below the median of 156 across 75 observational studies indexed under Multiple Organ Failure.

Browse Multiple Organ Failure studies →

Lead sponsor

Taoyuan General Hospital is the lead sponsor of 19 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients without severe arrhythmia admitted to the ICU of Taoyuan General Hospital.

Inclusion criteria

  • ICU patients in the 20-to-99 age range
  • Subjects agree to sign the Informed Consent Form and are willing to cooperate with Arterial pulse measurement

Exclusion criteria

Exclusion Criteria:

  • Subject has severe arrhythmia
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • ICU patient

    Pulse pressure of the radical artery was obtained by arterial line. The output of the transducer was connected to an IBM PC for analysis via an A/D converter with sampling rate = 250 datapoints/sec. The pulse spectrum was analyzed with the Fourier transformation using T (period) = 1 pulse time.

    Diagnostic Test: ICU patient

Interventions

  • Diagnostic testICU patient

    Our study is to measure the coefficient of variation of the HCV of the radial arterial pulse among ICU patients with multiple organ failures (MOF). Patients admitted to Taoyuan General Hospital were recorded during the 6 months study.

06

What researchers measure

Primary outcomes

  1. Coefficient of variation of harmonic magnitude

    We measure the blood pressure of participants with multiple organ failures (MOF) by pressure transducer during the 6 months study in the ICU of Taoyuan General Hospital. The radial artery pressure pulse of both hands are recorded with a pressure transducer fixed on the skin with tape and an adjustable belt with a small button to achieve suitable pressure.

    Time frame: 15 min

07

Study locations

1 of 1 sites recruiting
  • Taoyuan General Hospital, Ministry of Health and Welfare
    Taoyuan, 33004, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03827369
Lead sponsor
Taoyuan General Hospital
Responsible party
Sponsor
First posted
Feb 1, 2019
Start date
Apr 30, 2019
Primary completion
Dec 2020 (estimated)
Completion
Dec 2020 (estimated)
Last update
Mar 27, 2020

Study contacts

Tzu-Yi Chuang
Contact
revival_chuang@yahoo.com
886-3-3699721 ext. 3787
Tzu-Yi Chuang
principal investigator · Taoyuan General Hospital, Minstry of Healthy and Welfare

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion